Medindia

X

QIAGEN's GeneReader NGS System Streamlines Data Management for Labs

Wednesday, November 9, 2016 Corporate News J E 4
Advertisement
New middleware co-developed with Genohm ensures full chain of custody from Sample to Insight and integrates with most LIMS systems

HILDEN, Germany and CHARLOTTE, North Carolina, November 9, 2016 /PRNewswire/ --

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership with lab informatics company Genohm to empower GeneReader NGS System users with seamless data management by integrating the NGS workflow with their laboratory information management systems (LIMS). QIAGEN's Sample to Insight next-generation sequencing (NGS) solution is supported by GeneRead Link, a middleware co-developed by the two companies to ensure complete chain of custody from sample processing to final reports - with full connectivity into the leading LIMS systems. In addition, GeneReader NGS System customers who do not already have a LIMS solution can benefit from easy connectivity into Genohm's proprietary SLims solution to help manage all data across the laboratory. Both companies will continue to enhance GeneRead Link and adapt the middleware solution as required to support future GeneReader workflows.

"The value of next-generation sequencing comes from the insights a lab generates, and our GeneReader NGS System is uniquely designed to enable any laboratory to deliver actionable results from NGS. We are pleased to partner with Genohm to deliver GeneRead Link, greatly simplifying management of the sequencing information and providing connectivity with most LIMS platforms," said Jonathan Arnold, Senior Director of Marketing, Next Generation Sequencing, for QIAGEN. "Offering GeneReader NGS customers access to Genohm's proprietary SLims solution, an easy-to-use LIMS and electronic laboratory notebook system, broadens the solution to manage the whole laboratory's data."

Click here for the full press release

https://www.qiagen.com/about-us/press-releases/pressreleaseview?ID={58C92309-70ED-4A5B-A133-6DDDB3B41A3E}&lang=en

Contacts:

QIAGEN Investor Relations John Gilardi +49-2103-29-11711 e-mail: ir@QIAGEN.com      Public Relations Dr. Thomas Theuringer +49-2103-29-11826 e-mail: pr@QIAGEN.com GENOHM Davide Mauri +41-21-353-87-01 Head of Marketing and Communication davide@genohm.com

SOURCE Qiagen

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Manipal University Signs MoU With STEERLife
S
QIAGEN GeneReader NGS System to Relaunch in U.S. M...